Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2633236 | 0.91 | CNR1 (0.93) | CNR1CNR2 | |
| SCHEMBL674305 | 0.89 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL10144577 | 0.88 | CNR1 (0.85) | CNR1CNR2 | |
| SCHEMBL31529036 | 0.88 | CNR1 (0.76) | CNR1CNR2 | |
| SCHEMBL12289600 | 0.88 | CNR1 (0.76) | CNR1CNR2 | |
| SCHEMBL4924997 | 0.86 | CNR1 (0.91) | CNR1CNR2 | |
| SCHEMBL10171713 | 0.86 | CNR1 (0.59) | CNR1CNR2 | |
| SCHEMBL2627871 | 0.86 | CNR1 (0.89) | CNR1CNR2 | |
| SCHEMBL30961540 | 0.86 | CNR1 (0.89) | CNR1CNR2 | |
| SCHEMBL2627874 | 0.86 | CNR1 (0.89) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120095047-A1 | Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors | UNIVERSITY OF CONNECTICUT (US) | 2012-04-19 | — | — | US | disclosed |
| US-8084451-B2 | Heteropyrrole analogs acting on cannabinoid receptors | UNIVERSITY OF CONNECTICUT (US) | 2011-12-27 | — | — | US | disclosed |
| US-20100063050-A1 | NOVEL HETEROPYRROLE ANALOGS ACTING ON CANNABINOID RECEPTORS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095047-A1 | Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors | CNR2, CNR1, GPR18 | CNR1 2/4885CNR2 1/4885 |
| US-20100063050-A1 | NOVEL HETEROPYRROLE ANALOGS ACTING ON CANNABINOID RECEPTORS | CNR2, CNR1, GPR18 | CNR1 2/4885CNR2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.